Cargando…

Detection of postoperative plasma circulating tumour DNA and lack of CDX2 expression as markers of recurrence in patients with localised colon cancer

BACKGROUND: Colon cancer (CC) is a heterogeneous disease. Novel prognostic factors beyond pathological staging are required to accurately identify patients at higher risk of relapse. Integrating these new biological factors, such as plasma circulating tumour DNA (ctDNA), CDX2 staining, inflammation-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tarazona, Noelia, Gimeno-Valiente, Francisco, Gambardella, Valentina, Huerta, Marisol, Roselló, Susana, Zuniga, Sheila, Calon, Alexandre, Carbonell-Asins, Juan Antonio, Fontana, Elisa, Martinez-Ciarpaglini, Carolina, Eason, Katherine, Rentero-Garrido, Pilar, Fleitas, Tania, Papaccio, Federica, Moro-Valdezate, David, Nyamundanda, Gift, Castillo, Josefa, Espí, Alejandro, Sadanandam, Anguraj, Roda, Desamparados, Cervantes, Andrés
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7513635/ https://www.ncbi.nlm.nih.gov/pubmed/32967918 http://dx.doi.org/10.1136/esmoopen-2020-000847

Ejemplares similares

polyClustR: defining communities of reconciled cancer subtypes with biological and prognostic significance
por: Eason, Katherine, et al.
Publicado: (2018)

Precision Medicine to Treat Advanced Gastroesophageal Adenocarcinoma: A Work in Progress
por: Gambardella, Valentina, et al.
Publicado: (2020)

“Proteotranscriptomic analysis of advanced colorectal cancer patient derived organoids for drug sensitivity prediction”
por: Papaccio, Federica, et al.
Publicado: (2023)

A Machine-Learning Tool Concurrently Models Single Omics and Phenome Data for Functional Subtyping and Personalized Cancer Medicine
por: Nyamundanda, Gift, et al.
Publicado: (2020)

Integrative immune transcriptomic classification improves patient selection for precision immunotherapy in advanced gastro-oesophageal adenocarcinoma
por: Cabeza-Segura, Manuel, et al.
Publicado: (2022)

A Novel Statistical Method to Diagnose, Quantify and Correct Batch Effects in Genomic Studies
por: Nyamundanda, Gift, et al.
Publicado: (2017)

Neoadjuvant Chemotherapy in Locally Advanced Rectal Cancer
por: Papaccio, Federica, et al.
Publicado: (2020)

Heterocellular gene signatures reveal luminal-A breast cancer heterogeneity and differential therapeutic responses
por: Poudel, Pawan, et al.
Publicado: (2019)

Molecular profiling of advanced solid tumours. The impact of experimental molecular-matched therapies on cancer patient outcomes in early-phase trials: the MAST study
por: Gambardella, Valentina, et al.
Publicado: (2021)

Assessing molecular subtypes of gastric cancer: microsatellite unstable and Epstein-Barr virus subtypes. Methods for detection and clinical and pathological implications
por: Martinez-Ciarpaglini, Carolina, et al.
Publicado: (2019)

Personalized Medicine: Recent Progress in Cancer Therapy
por: Gambardella, Valentina, et al.
Publicado: (2020)

In the literature: October 2021
por: Gambardella, V., et al.
Publicado: (2021)

In the literature: July 2023
por: Gambardella, V., et al.
Publicado: (2023)

Analytical Validation of Multiplex Biomarker Assay to Stratify Colorectal Cancer into Molecular Subtypes
por: Ragulan, Chanthirika, et al.
Publicado: (2019)

Will Organoids Fill the Gap towards Functional Precision Medicine?
por: Papaccio, Federica, et al.
Publicado: (2022)

Short-term outcomes of colorectal cancer surgery in older patients: a novel nomogram predicting postoperative morbi-mortality
por: Moro-Valdezate, David, et al.
Publicado: (2022)

EPDR1 up-regulation in human colorectal cancer is related to staging and favours cell proliferation and invasiveness
por: Gimeno-Valiente, F., et al.
Publicado: (2020)

Epigenetic changes in localized gastric cancer: the role of RUNX3 in tumor progression and the immune microenvironment
por: Llorca-Cardeñosa, Marta Jessica, et al.
Publicado: (2016)

Is the tumour microenvironment a critical prognostic factor in early-stage colorectal cancer?
por: Nyamundanda, G, et al.
Publicado: (2019)

The 2(nd) Conference and Workshop of The Cancer Genome Atlas (TCGA) in India: Towards Team Science for Multi-omics Cancer Research in South Asia
por: Dixit, Santosh, et al.
Publicado: (2021)

In the literature: April 2020
por: Gambardella, Valentina, et al.
Publicado: (2020)

Epigenetic Mechanisms Are Involved in the Oncogenic Properties of ZNF518B in Colorectal Cancer
por: Gimeno-Valiente, Francisco, et al.
Publicado: (2021)

Circulating Tumor DNA in Stage III Colorectal Cancer, beyond Minimal Residual Disease Detection, toward Assessment of Adjuvant Therapy Efficacy and Clinical Behavior of Recurrences
por: Henriksen, Tenna Vesterman, et al.
Publicado: (2022)

Overlapping functions of Cdx1, Cdx2, and Cdx4 in the development of the amphibian Xenopus tropicalis
por: Faas, Laura, et al.
Publicado: (2009)

Functional interaction between the homeoprotein CDX1 and the transcriptional machinery containing the TATA-binding protein
por: Calon, Alexandre, et al.
Publicado: (2007)

Cdx1 and Cdx2 Exhibit Transcriptional Specificity in the Intestine
por: Grainger, Stephanie, et al.
Publicado: (2013)

ZNF518B gene up-regulation promotes dissemination of tumour cells and is governed by epigenetic mechanisms in colorectal cancer
por: Gimeno-Valiente, Francisco, et al.
Publicado: (2019)

Identification of Semaphorin 5A Interacting Protein by Applying Apriori Knowledge and Peptide Complementarity Related to Protein Evolution and Structure
por: Sadanandam, Anguraj, et al.
Publicado: (2008)

CDX1 and CDX2 Expression in Intestinal Metaplasia, Dysplasia and Gastric Cancer
por: Kang, Jung Mook, et al.
Publicado: (2011)

Probabilistic principal component analysis for metabolomic data
por: Nyamundanda, Gift, et al.
Publicado: (2010)

Circulating Tumor DNA Detection by Digital-Droplet PCR in Pancreatic Ductal Adenocarcinoma: A Systematic Review
por: Huerta, Marisol, et al.
Publicado: (2021)

Transduced caudal‐type homeobox (CDX) 2/CDX1 can induce growth inhibition on CDX‐deficient gastric cancer by rapid intestinal differentiation
por: Nakayama, Chiemi, et al.
Publicado: (2018)

Minimal residual disease in gastroesophageal adenocarcinoma: the search for the invisible
por: Tarazona, N., et al.
Publicado: (2022)

Microenvironmental niche divergence shapes BRCA1-dysregulated ovarian cancer morphological plasticity
por: Heindl, Andreas, et al.
Publicado: (2018)

Relationships Between the Expressions of CDX1 and CDX2 mRNA and Clinicopathologic Features in Colorectal Cancers
por: Kim, Gwang Ha, et al.
Publicado: (2005)

MCAM: A Database to Accelerate the Identification of Functional Cell Adhesion Molecules
por: Sadanandam, Anguraj, et al.
Publicado: (2008)

Neoadjuvant treatment for locally advanced unresectable and borderline resectable pancreatic cancer: oncological outcomes at a single academic centre
por: Roselló, Susana, et al.
Publicado: (2020)

Differential and longitudinal immune gene patterns associated with reprogrammed microenvironment and viral mimicry in response to neoadjuvant radiotherapy in rectal cancer
por: Wilkins, Anna, et al.
Publicado: (2021)

Immune landscape, evolution, hypoxia-mediated viral mimicry pathways and therapeutic potential in molecular subtypes of pancreatic neuroendocrine tumours
por: Young, Kate, et al.
Publicado: (2021)

A Cross-Species Analysis of a Mouse Model of Breast Cancer-Specific Osteolysis and Human Bone Metastases Using Gene Expression Profiling
por: Sadanandam, Anguraj, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_2n2f1tbv8tq87584tqdei3t0qd